• CRS • Reduction of inflammatory factor release (inhibitors, CRISPR-Cas9 knockdown) • Suicide genes (HSV-TK, iCasp9) • Application of glucocorticoids• GVHD • Infusion of allo CAR-T cells• MDSCs • Infusion of ATRA. This evidence concerns the gene TKT and graft versus host disease.